HOFSETH BIOCARE ASA (HBC.OL) Stock Balance Sheet
OSL:HBC - Euronext Oslo - NO0010598683 - Common Stock - Currency: NOK
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 22.56M | 20.87M | 29.88M | 47.21M | 170.71M | |||
| Cash Equivalents | N/A | N/A | 32.43M | N/A | 172.84M | |||
| Receivables | 18.85M | 14.85M | 14.07M | 10.09M | 14.27M | |||
| Inventories | 55.92M | 82.54M | 116.53M | 90.81M | 73.30M | |||
| Other Current Assets | 14.73M | 12.74M | 15.27M | 22.20M | 13.19M | |||
| Total Current Assets | 112.06M | 131.00M | 175.75M | 170.31M | 271.47M | |||
| Non-Current Assets | ||||||||
| PPE Net | 137.98M | 165.70M | 168.79M | 185.83M | 137.96M | |||
| Investments And Advances | 46.95M | 38.13M | 5.90M | 6.78M | 7.28M | |||
| Goodwill | N/A | N/A | N/A | N/A | N/A | |||
| Intangibles | 42.43M | 55.28M | 60.59M | 53.05M | 42.43M | |||
| Other Non-Current Assets | -1.00K | -1.00K | 1.00K | N/A | N/A | |||
| Total Non-Current Assets | 227.36M | 259.12M | 235.28M | 245.66M | 187.66M | |||
| TOTAL ASSETS | 339.42M | 390.12M | 411.03M | 415.97M | 459.13M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 59.24M | 39.69M | 13.39M | 14.52M | 11.65M | |||
| Accounts Payable | 93.63M | 55.16M | 145.75M | 124.17M | 84.96M | |||
| Other Current Liabilities | 15.56M | 157.03M | 13.08M | 12.25M | 9.57M | |||
| Total Current Liabilities | 168.42M | 251.88M | 172.23M | 150.93M | 106.18M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 111.64M | 97.10M | 89.96M | 123.31M | 85.42M | |||
| Other Non-Current Liabilities | -1.00K | N/A | 812.00K | 1.35M | 3.77M | |||
| Total Non-Current Liabilities | 110.95M | 96.42M | 90.09M | 123.98M | 88.51M | |||
| TOTAL LIABILITIES | 279.38M | 348.29M | 262.31M | 274.91M | 194.69M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | 0.00 | 0.00 | 0.00 | 0.00 | 15.48M | |||
| Additional Paid In Capital | 55.93M | 37.88M | 144.76M | 137.49M | 236.71M | |||
| Minority Interest | -689.00K | -687.00K | -686.00K | -685.00K | -684.00K | |||
| Common Shares | 4.11M | 3.95M | 3.95M | 3.58M | 3.58M | |||
| Other Shareholders' Equity | 0.00 | N/A | 0.00 | 0.00 | 8.68M | |||
| Shares Outstanding | 411.08M | 395.08M | 395.08M | 357.83M | 357.83M | |||
| Tangible Book Value per Share | 0.04 | -0.03 | 0.22 | 0.25 | 0.62 | |||
| Total Shareholders' Equity | 60.05M | 41.83M | 148.72M | 141.06M | 264.45M | |||
| TOTAL LIABILITIES AND EQUITY | 339.42M | 390.12M | 411.03M | 415.97M | 459.13M | |||
| Statistics | ||||||||
| Debt/Equity | 1.86 | 2.32 | 0.60 | 0.87 | 0.32 | |||
| Current Ratio | 0.67 | 0.52 | 1.02 | 1.13 | 2.56 | |||
| Return On Assets (ROA) | -36.92% | -27.35% | -33.43% | -30.40% | -22.24% | |||
| Return On Equity (ROE) | -208.67% | -255.06% | -92.38% | -89.65% | -38.60% | |||
All data in NOK , ROIC based on taxRate of 0.23